Investment
Features
FeesSafety
Academy
More
Pluang+

Rithm Capital (RITM) shows strong dividend sustainability with a 10.95% yield and a strong buy rating at current prices.

Analyst Insights
29 Sep 2026
Seeking Alpha
View Source
Bullish
Rithm Capital (RITM) shows strong dividend sustainability with a 10.95% yield and a strong buy rating at current prices.

Rithm Capital Corp. (RITM) maintains a stable dividend of $0.25 per share with a trailing twelve-month yield of 10.95% as of Q3 2026. The company’s core earnings consistently cover dividends, indicating high dividend sustainability through 2026 and into early 2027. Despite a cautious sector-wide dividend cut during the 2020 pandemic, RITM has steadily increased dividends since and currently trades below its projected book value, leading to a strong buy recommendation. The outlook considers rising interest rates and expected modest narrowing of net interest spreads, with RITM poised to outperform many mortgage REIT peers in this environment.

Rithm Capital’s sector comparative analysis is presented with Pluang market data as of Sep 29, 2026 18:51 WIB. For readers following Real Estate-sector US stocks, here is Pluang's market snapshot: of 26 priced stocks, 17 rose and 8 fell today. Notable movers include PLD at USD 131.93 with a -0.40% change and a typical hold time on Pluang of 102 days, SPG at USD 203.80 with a -0.36% change and 100% buy order activity, and EQIX at USD 1,014.62 with a +0.35% change and 100% sell order activity. The most notable figure is SPG's 100% buy order activity.

More News

FREELANDER debuts international test drive and brand event at 2026 Chery User Summit in China

FREELANDER debuts international test drive and brand event at 2026 Chery User Summit in China

FREELANDER participated in the 2026 Chery International User Summit in Wuhu, China, showcasing the international variant of its FREELANDER 8 model through a day-and-night program on October 19. The day featured the first international test drive on c...

Others
Bullish
1 hour ago
Disc Medicine to webcast APOLLO Phase 3 trial results of bitopertin for erythropoietic protoporphyria

Disc Medicine to webcast APOLLO Phase 3 trial results of bitopertin for erythropoietic protoporphyria

Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...

Market News
Neutral
3 hours ago
Bitcoin tops $82,000 amid talks of Putin, Trump, and Xi meeting on Ukraine.

Bitcoin tops $82,000 amid talks of Putin, Trump, and Xi meeting on Ukraine.

Bitcoin surged above $82,000 on October 18, reaching a 24-hour high of $82,183.56, following news of a proposed meeting between Russian President Vladimir Putin, U.S. President Donald Trump, and Chinese President Xi Jinping to discuss the Ukraine con...

Market News
Neutral
4 hours ago
Bitcoin shows strong $5.34M support at $81,677 on Coinbase order book snapshot

Bitcoin shows strong $5.34M support at $81,677 on Coinbase order book snapshot

A recent Coinbase order book snapshot revealed a significant $5.34 million buy order for Bitcoin at $81,677, representing a key support level about 0.40% below the midpoint price of $82,003. Total nearby buy orders amounted to $23.74 million, slightl...

Market News
Neutral
4 hours ago
Bitcoin, Solana, Near, and Hyperliquid hover near key support levels with mixed daily moves.

Bitcoin, Solana, Near, and Hyperliquid hover near key support levels with mixed daily moves.

On October 18, Bitcoin (BTC), Solana (SOL), Near Protocol (NEAR), and Hyperliquid (HYPE) traded close to their technical support ranges, showing mixed performance throughout the day. BTC hovered around $80,000–$81,000, SOL near $100–$102, NEAR at $4....

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App